Icon PLC $43.64

down -0.26


17/4/2014 08:10 PM  |  NASDAQ : ICLR  
Industries : Health Services / Medical Laboratories & Research
Get Trend Analysis Icon Get ICLR Trend Analysis - it has outperformed the S&P 500 by 27%

Partner Headlines

  1. Will Clinical Trial Specialist Icon's Latest Base Get Good Results?

    IBD
  2. Myriad Gaps Up To High On Reimbursement Rate Change

    IBD
  3. Aptiv Solutions to be Acquired by ICON for $143.5M

    Benzinga
  4. US Stock Futures Up Ahead Of Chicago PMI

    Benzinga
  5. UPDATE: Credit Suisse Initiates Coverage on ICON plc as Momentum is Poised ...

    Benzinga
  6. Benzinga's Top Initiations

    Benzinga
  7. Medical Researchers Break Into Top 10 Industry Groups

    IBD
  8. Stock Market Closes Lower But Well Off Session Lows

    IBD
  9. ICON Names Dr. Steve Cutler as COO

    Benzinga
  10. UPDATE: ISI Group Upgrades ICON plc Following Weaker PRXL Results

    Benzinga
  11. Earnings Season Holds Good Surprises From Top ADRs

    IBD
  12. Medical Research Firms Tap Drug Development Trend

    IBD
  13. Medical Research Firms Tap Drug Development Trend

    IBD
  14. Top 4 Small-Cap Stocks In The Medical Laboratories & Research Industry ...

    Benzinga
  15. ICON Begins Direct Trading on NASDAQ

    Benzinga
  16. A Peek Into The Market Before The Trading Starts

    Benzinga
  17. ICON to Acquire Clinical Trial Services Division of Cross Country Healthcare ...

    Benzinga
  18. UPDATE: Sterne Agee Reiterates Neutral Rating, Raises PT on ICON plc

    Benzinga
  19. Parexel Makes Buyout, Lifts Outlook, But Stock Slips

    IBD
  20. UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on ICON plc

    Benzinga
  21. Four European Stocks Worth a Look Now (DLPH, ICLR, IR, LYB)

    Benzinga
  22. Moves in Smaller Health Care Stocks (GMED, SEM, UAM, VRTX)

    Benzinga
  23. UPDATE: Jefferies Upgrades ICON to Buy on Management Confidence

    Benzinga
  24. UPDATE: ISI Group Initiates ICON Plc with Overweight, $26 PT on Scaling ...

    Benzinga
  25. ICON Acquires PriceSpective

    Benzinga
  26. UPDATE: Jefferies Raises Target to $18.50 on ICON

    Benzinga
  27. Sterne Agee Upgrades Icon from Underperform to Neutral, Raises PT to $21

    Benzinga
  28. ICON Selected by Shire as Global Strategic Partner for Clinical Research ...

    Benzinga
  29. Deutsche Bank Downgrades ICON to Hold

    Benzinga
  30. Market Roundup

    Benzinga
  31. ICON Announces Dr. Anthony Murphy To Retire From Board of Directors

    Benzinga
  32. ICON Acquires BeijingWits Medical Consulting Ltd

    Benzinga
  33. ICON Acquires BeijingWits Medical Consulting

    Benzinga
Trading Center